(Q47227156)

12 January 2018

title

Bifacial effects of engineering tumour cell-derived exosomes on human natural killer cells (English)

1 reference

12 January 2018

author name string

Qi Li

1

1 reference

12 January 2018

Qiuping Huang

2

1 reference

12 January 2018

Ting Huyan

3

1 reference

12 January 2018

Yilin Wang

4

1 reference

12 January 2018

Qingsheng Huang

5

1 reference

12 January 2018

Junling Shi

6

1 reference

12 January 2018

language of work or name

English

0 references

publication date

18 December 2017

1 reference

12 January 2018

Experimental Cell Research

published in

1 reference

12 January 2018

Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosomes/microvesicles as a mechanism of cell-to-cell communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Extracellular vesicles and viruses: Are they close relatives?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosomes: small vesicles participating in intercellular communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Relevance of splicing on tumor-released exosome landscape: implications in cancer therapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Tumor-released microvesicles as vehicles of immunosuppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

The biology of human natural killer-cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Adaptive immune responses mediated by natural killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

The effects of epidural anaesthesia and analgesia on natural killer cell cytotoxicity and cytokine response in patients with epithelial ovarian cancer undergoing radical resection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosomes as intercellular signalosomes and pharmacological effectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Targeting Tumor Antigens to Secreted Membrane Vesicles In vivo Induces Efficient Antitumor Immune Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Human tumor-derived exosomes down-modulate NKG2D expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Effects of simulated microgravity on primary human NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Hsp-70 is closely associated with the transferrin receptor in exosomes from maturing reticulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Using exosomes, naturally-equipped nanocarriers, for drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Elucidation of Exosome Migration across the Blood-Brain Barrier Model In Vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Microparticles: protagonists of a novel communication network for intercellular information exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Membrane vesicles as conveyors of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosome secretion: molecular mechanisms and roles in immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Exosomes and communication between tumours and the immune system: are all exosomes equal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Ectocytosis caused by sublytic autologous complement attack on human neutrophils. The sorting of endogenous plasma-membrane proteins and lipids into shed vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Targeting soluble proteins to exosomes using a ubiquitin tag.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.12.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2017.12.005

1 reference

12 January 2018

PubMed ID

29269076

1 reference

12 January 2018